A surgical system is disclosed including impedance sensors and a control circuit. The impedance sensors are configured to apply a therapeutic level of RF energy to tissue, sense a real time impedance of the tissue, sense a first tissue impedance based on an initial contact with the tissue, sense a second tissue impedance of the tissue without applying a therapeutic amount of RF energy to the tissue. The control circuit is configured to determine a control parameter of a motor based on the first tissue impedance and the second tissue impedance, determine a percentage of use of an end effector, detect a change of the real time impedance of the tissue, adjust the control parameter of the motor based on the change of the real time impedance and the percentage of use of the end effector, and control delivery of a therapeutic energy application to the tissue.

An ultrasonic device may include an electromechanical ultrasonic system that includes an ultrasonic transducer coupled to an ultrasonic blade. A method of delivering energy to the ultrasonic device may include sensing a vessel type in contact with the blade, determining that the vessel type is either a vein or an artery, and delivering power to the transducer based on the vessel type. Power may be applied to the transducer at a power level P that differs from a nominal power level Pn for a period T that differs from a nominal period Tn based on the vessel. The power level P may be lower than Pn for a period T that is longer than Tn when the vessel is a vein. Alternatively, the power level P my be greater than Pn for a period T that is shorter than Tn when the vessel is an artery.

Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.

Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.

A surgical system for sealing a hollow organ, the surgical system including: a pair of electrodes; a memory storing data which include patterns corresponding to predetermined burst pressure value; an electrosurgical generator configured to generate a high frequency current for sealing the hollow organ; and one or more processors configured to: perform the sealing by application of the high frequency current through the hollow organ; measure impedance of the hollow organ between the pair of electrodes with time during the performing the sealing; subsequent to performing the sealing, classify parameters related to the impedance as one of patterns corresponding to predetermined burst pressure value according to the data; and estimate the burst pressure value of the hollow organ based on the one of patterns.

Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.

Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.

A surgical system includes a power supply, a power stage coupled to the power supply for converting electric energy to a power signal, an audio output device, a sensor, and a controller coupled to the power supply, the power stage, and the audio output device. The controller is operably coupled to the sensor. The power stage is configured to transmit the power signal to a surgical instrument such as an electrosurgical instrument or a microwave instrument. The sensor may be disposed on the surgical instrument. The controller causes the audio output device to output sensory feedback during operation of the surgical generator based on sensor signals received from the sensor during a surgical procedure.

A generator, ultrasonic device, and method for controlling a temperature of an ultrasonic blade are disclosed. A control circuit coupled to a memory determines an actual resonant frequency of an ultrasonic electromechanical system comprising an ultrasonic transducer coupled to an ultrasonic blade by an ultrasonic waveguide. The actual resonant frequency is correlated to an actual temperature of the ultrasonic blade. The control circuit retrieves from the memory a reference resonant frequency of the ultrasonic electromechanical system. The reference resonant frequency is correlated to a reference temperature of the ultrasonic blade. The control circuit then infers the temperature of the ultrasonic blade based on the difference between the actual resonant frequency and the reference resonant frequency. The control circuit controls the temperature of the ultrasonic blade based on the inferred temperature

A method of treating or preventing acute respiratory distress syndromes (ARDS) includes advancing a cryogenic treatment element into a target bronchus of a mammal and exchanging cryogenic energy between the target bronchus and the cryogenic treatment element for a predetermined period of time until a target temperature of the target bronchus is reached to cause neuropraxia of nerves within the target bronchus.